scPharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Scpharmaceuticals

09/08/2022 14:25

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly
adjusted
loss of 35 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 30 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * scPharmaceuticals Inc's reported EPS for the quarter was a
loss
of 35 cents​.
    * The mean earnings estimate of analysts had risen by
about 8.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * scPharmaceuticals Inc shares had risen by 11.0% this
quarter and
gained 6.6% so far this year.
    * The company reported a quarterly loss of $9.7 million.
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 01:24 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.30          -0.35          Missed
 Mar. 31 2022      -0.31          -0.28          Beat
 Dec. 31 2021      -0.34          -0.27          Beat
 Sep. 30 2021      -0.31          -0.24          Beat